. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "complex(p(HGNC:CISH),p(HGNC:PRLR)) -| (complex(p(HGNC:PRL),p(HGNC:PRLR)) -> tscript(p(HGNC:STAT5A)))" . "complex(p(HGNC:PRL),p(HGNC:PRLR)) -> tscript(p(HGNC:STAT5A))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "We demonstrate that CIS produces a 70% inhibition of PRL signaling by a mechanism distinct from, and downstream of, the effect of SOCS-1 on JAK2. This inhibition involves association with the PRL receptor (PRLR), resulting in the inhibition of signal transducer and activator of transcription 5 (STAT5) activation. CIS binds the PRLR but inhibits signal transducer and activator of transcription 5 rather than JAK2." . . "Selventa" . . . . "2014-07-03T14:29:59.175+02:00"^^ . . .